The process through which cells spontaneously arrange themselves into functional clusters has intrigued biologists for decades. At the heart of this phenomenon lies an intricate ballet of gene expression, signal diffusion, and mechanical forces. Until now, efforts to predict or manipulate this choreography relied heavily on laborious trial-and-error experiments, often yielding inconsistent or unpredictable results. The Harvard team’s approach circumvents this limitation by positing that the collective behavior of cells can be captured through mathematical models, where the parameters defining genetic networks and signal responses are tuned via optimization algorithms.

Central to this methodology is automatic differentiation, a computational technique initially developed to train deep neural networks by accurately and efficiently calculating gradients of complex functions. The novel application of automatic differentiation in this biological context allows researchers to assess how infinitesimal changes in any component of a gene regulatory network influence the emergent behavior of an entire tissue. This sensitivity analysis enables the discovery of “rules” or pathways that cells must follow to achieve a desired morphological outcome, effectively opening a reverse-engineering route in developmental biology.

To test and demonstrate their framework, the researchers constructed simulations embodying clusters of cells categorized into two archetypes: source cells and proliferating cells. Source cells, marked in red in their schematic visualizations, act as stationary emitters of growth factors. Proliferating cells, depicted in gray, respond dynamically to these chemical cues by dividing at rates modulated by the concentration gradients of the secreted molecules. Through iterative computational learning, the system optimized its gene regulatory parameters to achieve horizontal elongation of the cell cluster, a controlled morphogenetic behavior that echoes natural developmental processes.

Delving deeper, the learned gene network revealed an elegant regulatory motif. The receptor gene expressed by the proliferating cells activates only upon sensing the external growth factor emitted by source cells. Once activated, this receptor gene suppresses the cell division propensity, effectively concentrating proliferative activity toward the extremities of the cluster. This precise spatial control of division underpins the emergent shape, demonstrating how gene network dynamics intertwine with chemical gradients to orchestrate tissue architecture.

Such integrative modeling offers unprecedented opportunities for predictive bioengineering. Instead of manually tweaking genes or signaling molecules to guess their effects on tissue shape, scientists can now deploy computational pipelines to simulate and invert developmental scenarios. For example, one might specify a desired outcome—be it a spheroid with distinct proliferative zones or an elongated cellular formation—and let the algorithm determine the requisite genetic and biochemical parameters to induce such form. This paradigm shift could accelerate the design of artificial organs, optimize stem cell cultures, or even provide insights into pathological growth patterns such as tumors.

The implications extend beyond biological shape control. By combining physics-based models—accounting for cellular adhesion, mechanical tension, and chemical diffusion—with differentiable programming, the researchers provide a scalable approach to complex multicellular systems. This holistic perspective acknowledges that cellular behavior emerges not only from internal gene networks but also from the interplay with surrounding cells and environmental cues. Consequently, this framework lays foundational groundwork for systems biology, where computational tools unify molecular, biophysical, and mechanical factors driving morphogenesis.

Graduate student Ramya Deshpande, co-leading the study, emphasized the collaborative potential between computation and experimentation. As predictive models mature and integrate empirical data, biological experiments can shift from exploratory to hypothesis-driven workflows. Researchers might, for instance, synthesize cells with genetically encoded circuits prescribed by the algorithm, then observe real-world formation patterns to validate and refine the computational predictions. This cyclic interplay could substantially reduce the time to engineer functional tissues with predefined architectures.

Postdoctoral investigator Francesco Mottes highlighted the role of automatic differentiation in scaling these models. Traditional systems biology approaches often encounter computational bottlenecks when handling high-dimensional gene networks and cellular interactions. Automatic differentiation, with its efficient gradient computation capabilities, overcomes these challenges, enabling routine optimization of intricate biological systems. Mottes envisions that as models become both predictive and experimentally calibrated, they may drive a future where growing complex organs in vitro becomes a practical reality rather than science fiction.

The study’s innovative use of differentiable programming in biological morphogenesis also resonates with broader trends in computational bioengineering. By integrating mathematical biology, applied physics, and artificial intelligence, the framework exemplifies an interdisciplinary fusion vital for tackling life’s complexities. Researchers across developmental biology, synthetic biology, and tissue engineering stand to benefit from these advances, which democratize access to sophisticated simulation and design tools once limited to computer science domains.

Importantly, the research is not just a theoretical exercise but is aligned with experimental feasibility. The authors detail simulation results showing how source cells producing a consistent chemical gradient influence spatial patterns of proliferation, mimicking processes observed in vivo. The capability to modulate division propensities spatially lays the groundwork for engineering morphogenetic fields, potentially controlling not only shape but also function by dictating cellular differentiation zones.

The study, published in Nature Computational Science, represents a significant stride toward transforming how scientists understand and manipulate life’s architectural blueprint. Supported by agencies such as the Office of Naval Research and the NSF AI Institute of Dynamic Systems, this collaborative effort unites computational ingenuity with biological insight. The dedication of the paper to former Harvard postdoc Alma Dal Co honors the contributions of researchers advancing this frontier.

Looking ahead, the research community anticipates that such computational frameworks will evolve to incorporate richer cell types, signaling pathways, and mechanical interactions. As experimental data increasingly feeds into machine learning pipelines, the predictive control of developmental systems inches closer to reality. The dream of programming cells to self-assemble into tissues or organs with custom features now seems achievable within the coming decades, ushering in a new era of precision bioengineering driven by differentiable programming.

Subject of Research: Cells

Article Title: Engineering morphogenesis of cell clusters with differentiable programming

News Publication Date: 13-Aug-2025

Web References:
https://www.nature.com/articles/s43588-025-00851-4
http://dx.doi.org/10.1038/s43588-025-00851-4

Image Credits: Brenner group / Harvard SEAS

Keywords: Artificial intelligence, Computer modeling, Computer simulation, Engineering, Systems biology, Cell biology, Computational biology, Mathematical biology, Developmental biology, Applied physics, Mathematical physics, Statistical physics

The foundation of this revolution rests upon a remarkable insight: when provided with the proper environment, cells possess an innate ability to organize themselves and function effectively. This understanding shapes the development of scaffolds that closely resemble natural biological structures, thereby supplying cells with essential cues for growth and interaction. These specially designed scaffolds are critical for enabling engineers to create synthetic tissues that closely mimic the functionality of real organs.

Shiwarski’s introduction of collagen-based, high-resolution scaffolds—dubbed CHIPS—marks a significant leap forward in tissue engineering. These unique structures are internally perfusable and can seamlessly integrate with a vascular organ-on-a-chip system to mimic the dynamic cellular environment found within human tissues. Collaborating with Adam Feinberg, a distinguished professor at Carnegie Mellon University, Shiwarski’s team has shared their findings in a notable publication featured on the cover of the prestigious journal Science Advances. The article highlights innovative strategies for utilizing 3D bioprinting to forge fully biologic tissue systems.

A pivotal aspect of the research involves leveraging additive manufacturing techniques to unlock new potentials for generating functional replacement tissues. In addition to creating tissues, these models offer researchers valuable insights into various diseases, including diabetes and hypertension. The current methodology adopted for studying these conditions—in vitro microfluidic modeling—utilizes minute channels embedded within microchips to simulate blood vessel behaviors. Notably, these microfluidic platforms have traditionally relied on silicone materials, which, despite being useful, restrict the potential for biological interactions due to their synthetic nature.

Shiwarski emphasizes the transformative potential of their collagen-based scaffolds, asserting that they allow cells to thrive in an environment that closely replicates their natural conditions. Unlike traditional microfluidic devices, which typically uphold rigid designs, these bioengineered scaffolds are composed entirely of collagen. This fundamental difference enables cells not only to interact with the structure but also to grow and self-organize into functional tissues, effectively revolutionizing the landscape of tissue engineering.

This newfound capability was demonstrated when the team successfully combined collagen scaffolds with vascular cells and pancreatic cells. The result was a striking mimicry of natural physiological functions, exemplified by insulin secretion in response to glucose levels. This ability to replicate vital biological processes propels forward the prospect of developing organs capable of addressing insulin-dependent diabetes—offering hope for more effective treatment modalities in the future.

Central to supporting the growth of these cellularized collagen scaffolds is a customized perfusion bioreactor system named VAPOR. This inventive platform establishes a secure connection between the soft tissue scaffolds and the fluidic system, allowing researchers to manipulate and control the environment in which the tissues are cultivated. Remarkably, Shiwarski notes that this bioreactor design permits easy assembly, likening the process to playing with Lego blocks—demonstrating an intuitive and user-friendly approach to complex tissue engineering tasks.

Moreover, unlike conventional microfluidic devices that are limited by their flat configurations, Shiwarski’s team has demonstrated the capacity to create intricate non-planar three-dimensional networks with their soft organic materials. By crafting helical vascular networks inspired by the structure of DNA, the researchers harness the advantages of microfluidics—such as precise control over fluid dynamics—while incorporating the innate advantages of natural biomaterials.

As Shiwarski concludes, the transformative approach taken by his team shapes the future of tissue engineering. By providing cells with an environment that closely mirrors their natural surroundings, it enables them to thrive and execute their intrinsic biological functions. Consequently, the researchers hope to bridge the gap between simplified two-dimensional models and complex animal studies, paving the way for comprehensive examinations into human-specific diseases.

Looking ahead, Shiwarski’s ambition is to exploit this sophisticated bioprinting platform to delve deeper into vascular diseases such as hypertension and fibrosis. These investigations aim to illustrate how such conditions impact tissue development and functionality—a critical step toward advancing our understanding of human health. The ultimate aspiration lies in transcending traditional animal models, instead implementing more accurate human-based systems that will enhance the fidelity of biological research.

Shiwarski also emphasizes the team’s commitment to open science, ensuring that all models and designs from this groundbreaking project are freely accessible to the research community. By encouraging collaboration and innovation across various scientific disciplines, Shiwarski aims to galvanize efforts toward unraveling the complexities of diseases and fostering a new generation of medical solutions to address pressing global health challenges.

Amidst the pioneering studies and innovations, the underlying message of Shiwarski’s research reflects an unfaltering belief in the power of nature and the innate programming of cells. By recreating ideal environments for cellular growth and interaction, the researchers not only advance the field of tissue engineering but also lay the groundwork for future breakthroughs that could transform the landscape of regenerative medicine as we know it. The vision of producing fully functional human organs through 3D bioprinting may no longer remain a distant dream; instead, it draws tantalizingly close to becoming a reality driven by cutting-edge research and resolute scientific inquiry.

In this age of transformative science, it is crucial to remain vigilant in monitoring the implications of such advancements as they emerge. The excitement surrounding Shiwarski’s work reflects not just immediate concerns but also broader questions related to ethics, accessibility, and the future of healthcare in an ever-evolving biotechnological landscape.

Although these scientific achievements signal a bright future for organ fabrication and disease modeling, navigating the complexities of translating such innovations into viable clinical applications requires careful consideration. While the potential to revolutionize patient care exists, the path forward must ensure that scientific integrity, ethical standards, and public trust remain at the forefront of these groundbreaking endeavors.

As researchers like Shiwarski forge new pathways in tissue engineering, anticipating the eventual impact on clinical practice and patient outcomes becomes paramount. The creation of organ-like structures promises to herald an era where patients may benefit from customized therapies and solutions that accurately reflect human biology and biochemistry. With these daring scientific strides and the zeal for discovery, the horizon glows with the promise of pioneering transformations that could shape the future of medicine.

Subject of Research: 3D bioprinting of collagen-based scaffolds
Article Title: 3D bioprinting of collagen-based high-resolution internally perfusable scaffolds for engineering fully biologic tissue systems
News Publication Date: 23-Apr-2025
Web References: Science Advances DOI
References: N/A
Image Credits: Credit: Daniel Shiwarski

Keywords